Navigation Links
Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
Date:12/1/2009

BETHESDA, Md., Dec. 1 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.

Under the terms of the agreement, Bayer Schering Pharma had an option until January 5, 2010 to license a specific BiTE antibody targeting an undisclosed target. The option exercise triggers a formal collaboration between Micromet and Bayer Schering Pharma on the development of the BiTE antibody. Micromet will be primarily responsible for the preclinical development of the BiTE antibody, and will collaborate with Bayer through the completion of phase 1 clinical trials, at which point Bayer Schering Pharma will assume full control of the further development and commercialization of the BiTE antibody. Micromet will receive an option exercise fee of Euro 5 million (approx. $7.5 million), and is eligible for further milestone payments of up to Euro 285 million (approx. $426 million) in total and up to double digit royalties on net sales of the BiTE antibody. In addition, Micromet will be reimbursed for its R&D expenses.

"BiTE antibodies represent a promising approach to cancer therapy," said Dr. Karl Ziegelbauer, Head Therapeutic Research Oncology of Bayer Schering Pharma AG. "We are pleased with the progress of the program since the signing of the agreement in January of this year. We are looking forward to developing a new treatment for patients with solid tumors and to further advance novel therapeutic options in our oncology portfolio."

Jens Hennecke, Micromet's Senior Vice Presi
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
2. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
5. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
6. Bayers Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
7. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
8. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
9. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...   Direct to implant, or "one step," ... option for many women with BRCA (BReast CAncer) ... cancer risk, or with breast cancer. Traditionally, post-mastectomy ... second surgery to insert permanent implants, but immediate ... mastectomy can be a medically and cosmetically effective ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress Solutions, ... market, announced today the company has signed a letter ... company based in Huntsville, AL . ... in the staffing and recruitment of telemedicine physicians. Consideration ... the final agreement, which is expected by June 30, ...
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Taiho Pharmaceutical Co., Ltd. announced on May 31 ... the novel combination antimetabolite TAS-102 will start in June ... double-blind, placebo-controlled Phase III trial that compares TAS-102 with ... safety of TAS-102 when administered to patients with advanced ...
...  Today, at the 52nd annual New Clinical Drug Evaluation ... of Psychiatry at the University of California, Los Angeles ... presented the results from the first 6-subject cohort of ... effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic ...
Cached Medicine Technology:Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 2Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 4Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 5
(Date:5/24/2013)... France: A new investigational device - the Helio System ... XT Transcatheter Heart Valve was successfully deployed in all ... its use in high-risk aortic insufficiency reported at EuroPCR ... anchor to help stabilise the SAPIEN XT valve for ... heart are captured between the transcatheter heart valve and ...
(Date:5/24/2013)... Palm Beach Gardens, FL (PRWEB) May 24, 2013 ... plastic surgeons jealous, Dr. Greg DeLange of the ... each of the hosts of KOOL 105.5 FM’s popular morning ... on the air about their experiences and their satisfaction with ... Estetica Institute, a cutting-edge facility located in Palm Beach Gardens, ...
(Date:5/24/2013)... Residents of San Diego have a new ... expert, and Certified Russian Kettlebell Instructor, Cody Bramlett has ... San Diego, California. The classes take place Monday through ... Initial sign-ups are available online and by clicking ... for years. The bootcamps being offered in San ...
(Date:5/24/2013)... DiscountHumidifiers.com, an eCommerce store specializing in economical humidification ... line of humidifiers. These tastefully designed humidifiers are ... styles to choose from. , The ... piece – yet its functionality is not easily recognized. ... an inconspicuous humidifying appliance. With the built-in aroma diffuser, ...
(Date:5/24/2013)... the first conference of its kind, Impacts World ... and decision makers from politics, business and civil ... integrated climate impact research across sectors and scales. ... World 2013 on May 27th, 1pm to 1:55pm ... , Speakers include: , Connie Hedegaard, ...
Breaking Medicine News(10 mins):Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2
... , ALEXANDRIA, Va., Oct. 28 The same reassuring voice ... poison emergency may be the same person answering your questions ... centers are among the first responders helping America respond to ... a variety of ways. , A few examples: , ...
... microorganisms, and microbial cells found in the human gut are ... However, little is known about the ways in which ... That is why gastroenterologists at Rush University Medical Center ... U.S. Department of Defense to chart the presence of microorganisms ...
... reduce eyestrain, poor posture, study finds , WEDNESDAY, Oct. ... help reduce the level of pain linked to poor ... shouldn,t just assume that problems will be solved by ... chairs. It,s also important to make sure the furniture ...
... Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical ... announced today that the Food and Drug Administration has ... the Company,s BIOGUARD(TM) barrier gauze wound dressings as Class ... its initial market clearance on February 25, 2009, via ...
... BLOOMINGTON, Minn., Oct. 28 The Child Neurology Foundation ... Spasms Awareness Week (October 11-17) that will go towards ... of epilepsy. , "Due to its rare nature, ... as it should be," said Lawrence Brown, M.D., Associate ...
... , WEDNESDAY, Oct. 28 (HealthDay News) -- Letting children sleep ... overweight or obese, a new study suggests. , Researchers ... tended to be heavier (as measured by body mass index, ... who slept less than eight hours a night, those who ...
Cached Medicine News:Health News:American Association of Poison Control Centers: Count U.S. Poison Centers Among First Responders in H1N1 Flu Pandemic 2Health News:Gastroenterologists explore relationship between bacteria in the gut and breast cancer 2Health News:Gastroenterologists explore relationship between bacteria in the gut and breast cancer 3Health News:Takes a Pro to Make Offices Pain-Free 2Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 2Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 3Health News:FDA Issues Guidance for Derma Sciences' Exclusive Wound Dressing With pDADMAC 4Health News:Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms 2Health News:Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms 3Health News:Let Kids Sleep Late on Weekends to Fight Fat: Study 2Health News:Let Kids Sleep Late on Weekends to Fight Fat: Study 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: